Alto Neuroscience (ANRO) Invested Capital (2022 - 2026)
Alto Neuroscience (ANRO) posted Invested Capital of $235.44 million for Q2 2026, up 64.0% from $143.53 million a year earlier but down 9.2% from the prior quarter.
Powered by 
Analysis
Alto Neuroscience (ANRO) Invested Capital (2022 - 2026) Analysis & Trends
For FY2025, Alto Neuroscience's Invested Capital came in at $167.9 million, up 3.8% from FY2024.
- In prior years, Alto Neuroscience's Invested Capital was $161.71 million in FY2024 and -$61.81 million in FY2023.
- Quarterly Invested Capital has run from a low of -$61.81 million in Q4 2023 to a high of $259.39 million in Q1 2026 over five years.
- On a year-over-year basis, Invested Capital has increased in each of the last three quarters, with growth averaging 10.0% over the last six quarters.
- According to Business Quant data, Invested Capital for the three prior quarters was $259.39 million (Q1 2026), $167.9 million (Q4 2025) and $131.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 89.77 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 126.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 76.32 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 98.72 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 45.14 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 68.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 39.27 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 151.97 Bn |
| 10 | Alto Neuroscience | 1.14 Bn | 139.96 Mn | - | 310.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 310.01 Mn |
| Jun 30, 2026 | 235.44 Mn |
| Mar 31, 2026 | 259.39 Mn |
| Dec 31, 2025 | 167.90 Mn |
| Sep 30, 2025 | 131.87 Mn |
| Jun 30, 2025 | 143.53 Mn |
| Mar 31, 2025 | 159.04 Mn |
| Dec 31, 2024 | 161.71 Mn |
| Sep 30, 2024 | 175.21 Mn |
| Jun 30, 2024 | 189.83 Mn |
| Mar 31, 2024 | 203.06 Mn |
| Dec 31, 2023 | -61.81 Mn |
| Dec 31, 2022 | -28.94 Mn |
API Access
Alto Neuroscience Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=ANRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "ANRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=ANRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();